The German pharmaceutical and chemical company Bayer, a plaintiff in the United States due to the controversial weed glyphosat to pay a plaintiff to pay $ 2.1 billion.
class = “Mediannet-inline-Adv”>
Bayer continues to lose the lawsuits filed by those who claim that the agricultural drug containing Glyphosate in the USA is an important element that triggers cancer formation.
In the court in the US state of Georgia, the jury ruled on Friday, a plaintiff who claims that Bayer’s weed mortgopic product caused damage to cancer, the German company paid $ 2.1 billion, including 65 million compensation compensation.
The jury also decided that Bayer did not make enough explanations about the potential risks of the use of roundup and that he was responsible for warning the plaintiffs about the dangers of the drug.
The amount of $ 2.1 billion was recorded as one of the highest compensation in the cases filed due to agricultural drugs containing Glyfosate called Roundup in the USA.
class = “Mediannet-inline-Adv”>
Bayer, said in a statement, rejecting the allegations about Glyphosat, the overwhelming weight of scientific evidence and the consensus of regulatory institutions and the world -wide scientific assessment of the jury did not participate in the decision of the jury said. As in all other cases, the company will appeal the final decision in the state of Georgia. The German company also said that compensation in the cases reaching the final decisions has been reduced by 90 percent in general compared to the original jury decisions.
Following the decision, Bayer’s shares lost more than 6 percent in the stock market today. In 2018, Bayer was sentenced to billions of dollars of a fine and compensation in the cases filed by those who claim that the agricultural company Monsanto, which was developed by the US agricultural company Monsanto for $ 63 billion, was an important element that triggered the formation of cancer of the Glyphosate named Roundup.
While Bayer rejected the allegations about Glyphosat, the International Cancer Research Agency (IARC) in 2015 classified Glyphosat as carcinogenic.
Bayer announced in 2020 that he had reached an agreement in the US cases and that the plaintiffs would be paid 10.9 billion dollars. Despite the agreement, the company faces over 60,000 cases for Roundup. The German company allocated 5.9 billion dollars for the legal response for these cases.
